Skip to main content
Bioton S.A. logo

Bioton S.A. — Investor Relations & Filings

Ticker · BIO ISIN · PLBIOTN00029 LEI · 259400I5R1L3OPCGII81 WAR Manufacturing
Open in API
Filings indexed 697 across all filing types
Latest filing 2023-10-31 Interim / Quarterly Rep…
Country PL Poland
Listing WAR BIO

About Bioton S.A.

https://bioton.com/en/

Bioton S.A. is a biotechnology company focused on providing comprehensive solutions for diabetes care. The company's core activity is the development and production of recombinant human insulin, positioning it as a significant commercial manufacturer globally. Its operations cover the full biotechnological process, from DNA research and development to the manufacturing and marketing of finished medicinal products. The product portfolio is centered on various forms of insulin and is complemented by modern automatic injection systems designed to facilitate effective diabetes treatment for patients.

Recent filings

Filing Released Lang Actions
Informacja dodatkowa do Raportu Q3 2023
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report ('RAPORT KWARTALNY') for the period ending September 30, 2023. It contains substantive financial data, including consolidated income statements, balance sheet segments, and geographical revenue breakdowns, rather than just an announcement or certification. It fits the definition of an Interim/Quarterly Report (IR). 9M 2023
2023-10-31 Polish
Sprawozdanie Finansowe Q3 2023 Grupa Kapitałowa Bioton S.A.
Interim / Quarterly Report Classification · 100% confidence The document is a 'Skonsolidowany rozszerzony raport kwartalny' (Consolidated Extended Quarterly Report) for the period ending September 30, 2023. It contains detailed financial statements, including the Consolidated Income Statement, Consolidated Balance Sheet, and Statement of Comprehensive Income. As it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). 9M 2023
2023-10-31 Polish
Wybrane skonsolidowane dane 1H 2023
Earnings Release Classification · 99% confidence The document contains consolidated financial data ("SKONSOLIDOWANE DANE") for a specific period, comparing H1 2023 (01.01.2023 - 30.06.2023) with H1 2022 (01.01.2022 - 30.06.2022). It includes key line items like net sales, gross profit, net profit, cash flows, balance sheet totals (assets, liabilities, equity), and per-share metrics (EPS, book value). This structure, covering a six-month period comprehensively, strongly indicates an Interim/Quarterly Report, which aligns with the definition of 'Interim / Quarterly Report' (IR). It is not a full Annual Report (10-K) as the period covered is only six months. H1 2023
2023-08-31 Polish
Wybrane jednostkowe dane 1H 2023
Earnings Release Classification · 99% confidence The document presents detailed, comparative financial data for BIOTON S.A. covering two semi-annual periods (01.01.2022 - 30.06.2022 and 01.01.2023 - 30.06.2023). It includes key line items like Net Sales Revenue, Gross Profit, Net Profit/Loss, Cash Flows, Balance Sheet items (Assets, Liabilities, Equity), and per-share metrics (EPS, Book Value). This structure is characteristic of a comprehensive financial report covering a period shorter than a full year, specifically a half-year report. The Polish title 'DANE JEDNOSTKOWE' (Individual Data) and the period ending June 30th strongly suggest an Interim/Quarterly Report, which aligns best with the 'Interim / Quarterly Report' definition (IR). It is not an Earnings Release (ER) because it contains detailed balance sheet and cash flow statements, not just highlights. It is not a 10-K as the period covered is only six months. H1 2023
2023-08-31 Polish
Raport biegłego rewidenta 1H 2023 skonsolidowane
Audit Report / Information Classification · 99% confidence The document is titled 'RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU' (Independent Auditor's Review Report) concerning an 'śródrocznego skróconego skonsolidowanego sprawozdania finansowego' (interim condensed consolidated financial statement) for the period ending 30.06.2023. This explicitly indicates an audit or review report related to periodic financial statements, but it is not the full Annual Report (10-K). The definition for Audit Report / Information (AR) covers 'Standalone audit reports, applied accounting principles, and results of internal or regulatory stress tests (excluding full Annual Reports)'. Since this is a formal review report on interim financials, AR is the most appropriate classification, distinct from the comprehensive IR (Interim Report) or 10-K (Annual Report). The document length (3580 chars) confirms it is the report itself, not just an announcement. H1 2023
2023-08-31 Polish
Raport biegłego rewidenta 1H 2023 jednostkowe
Audit Report / Information Classification · 99% confidence The document is titled "RAPORT NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z PRZEGLĄDU" (Independent Auditor's Review Report) concerning the 'skróconego śródrocznego jednostkowego sprawozdania finansowego' (condensed interim individual financial statements) for the period ending June 30, 2023. This document explicitly details the scope and conclusion of a review performed by an independent auditor on interim financial statements. This aligns perfectly with the definition of an Audit Report / Information (AR), which covers standalone audit reports and results of internal/regulatory stress tests, distinguishing it from a full Annual Report (10-K) or a general Earnings Release (ER). The content is the audit/review opinion itself, not an announcement of its publication. H1 2023
2023-08-31 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.